[1. Elghetany TM, Bhatla T. Myelodysplastic Syndromes and Myeloproliferative Disorders. Lanzkowsky P. Hofmann I. Jeffrey M. Lipton Lanzkowsky’s Manual of Pediatric Hematology and Oncology. Sixth Edition Elsevier. 2016, London, 348-351.]Search in Google Scholar
[2. Hasle H, Niemeyer CM, Chessells JM. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia. 2003;17(2):277-282. DOI: 10.1038/sj.leu.240276510.1038/sj.leu.240276512592323]Open DOISearch in Google Scholar
[3. Disperati P, Ichim CV, Tkachuk D. Progression of myelodysplasia to acute lymphoblastic leukaemia: implications for disease biology. Leuk Res. 2006;30:233-239. DOI: 10.1016/j.leukres.2005.06.01110.1016/j.leukres.2005.06.01116046234]Open DOISearch in Google Scholar
[4. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;1145(5):937-51. DOI: 10.1182/blood-2009-03-20926210.1182/blood-2009-03-20926219357394]Open DOISearch in Google Scholar
[5. Tefferi A. Pathogenesis of myelofibrosis with myeloid metaplasia. J Clin Oncol. 2005;23(33):8520-30. DOI: 10.1200/JCO.2004.00.9316 10.1200/JCO.2004.00.931616293880]Open DOISearch in Google Scholar
[6. Das P, Deepali J, Das R, Garewal G. Hyperfibrotic myelodysplastic syndrome: a report of three cases from north India. Turk J Hematol. 2009;26:93-6.]Search in Google Scholar
[7. Bowen D, Culligan D, Jowitt S, Kelsey S, Mufti G, Oscier D, et al. Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes. Br J Haematol. 2003;120(2):187-200. DOI: 10.1046/j.1365-2141.2003.03907.x10.1046/j.1365-2141.2003.03907.x12542475]Open DOISearch in Google Scholar
[8. Porwit A, Saft L. The AML-MDS interface-leukemic transformation in myelodysplastic syndromes. J Hematopathol. 2011;4:69-79. DOI: 10.1007/s12308-011-0088-610.1007/s12308-011-0088-6]Search in Google Scholar
[9. Diem H. Myelodysplasia. Tehml H, Diem H, Haferlach T. Color Atlas of Hematology - Practical Microscopic and Clinical Diagnosis. 2nd revised edition 2004. Munich, 106-9.]Search in Google Scholar
[10. Glaubach T, Robinson L.J, Corey S.J Pediatric Myelodysplastic Syndromes: They Do Exist! J Pediatr Hematol Oncol. 2014;36:1-7. DOI: 10.1097/MPH.000000000000004610.1097/MPH.000000000000004624345881]Search in Google Scholar
[11. Elghetany TM. Myelodysplastic syndromes in children: a critical review of issues in the diagnosis and classification of 887 cases from 13 published series. Arch Pathol Lab Med. 2007;131:1110-6.10.5858/2007-131-1110-MSICAC17617000]Search in Google Scholar
[12. Cîrstea M, Coliță A, Ionescu B, Ghiaur A, Vasilescu D, et al. Therapy-related myelodysplastic syndrome after successful treatment of acute promyelocytic leukemia: case report and literature review. Rev Romana Med Lab. 2017;25(2):165-79. DOI: 10.1515/rrlm-2017-001310.1515/rrlm-2017-0013]Open DOISearch in Google Scholar
[13. Camitta BM. Diseases of blood: Splenomegaly. Kliegman RM. Behrman RE, Jenson HB, Waldo E, Nelson Textbook of Pediatrics. 18th edition, Philadelphia, Elsevier, 2008, 2091-2.]Search in Google Scholar
[14. Leguit RJ, Van Den Tweel J.G. The pathology of bone marrow failure. Histopathology. 2010;57(5):655-670. DOI: 10.1111/j.1365-2559.2010.03612.x10.1111/j.1365-2559.2010.03612.x20727024]Open DOISearch in Google Scholar
[15. Bănescu C, Benedek I, Duicu C, Demian S, Voidăzan S. Cytogenetic findings and their prognostic impact in myelodysplastic syndrome patients. Rev Romana MedLab. 2011;19(2):139-47.]Search in Google Scholar
[16. Della Porta MG, Malcovati L. Myelodysplastic syndromes with bone marrow fibrosis, Haematol Hematol J. 2011;96:180-3. DOI: 10.3324/haematol.2010.03987510.3324/haematol.2010.039875303168221282718]Open DOISearch in Google Scholar
[17. Geddes AD, Bowen DT, Jacobs A. Clonal karyotype abnormalities and clinical progress in the myelodysplastic syndrome, Br J Haematol. 1990;76(2):194-202. DOI: 10.1111/j.1365-2141.1990.tb07871.x10.1111/j.1365-2141.1990.tb07871.x2094322]Open DOISearch in Google Scholar
[18. Bernasconi P, Klersy C, Boni M. Does cytogenetic evolution have may any prognostic relevance in myelodysplastic syndromes? Ann Hematol. 2010;89:545-551. DOI: 10.1007/s00277-010-0927-z10.1007/s00277-010-0927-z20217086]Open DOISearch in Google Scholar
[19. Koppel A, Schiller G. Myelodysplastic syndrome: an update on diagnosis and therapy. Curr Oncol Rep. 2008 10(5):372-378. DOI: 10.1007/s11912-008-0058-z10.1007/s11912-008-0058-z18706264]Open DOISearch in Google Scholar
[20. Xiaojun KS, Xu Min L. Hypocellular myelodysplastic syndrome with myelofibrosis in acute myeloid leukemia transformation: A case report. Oncol Lett. 2015;10:422-4.10.3892/ol.2015.3247448714026171043]Search in Google Scholar